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There is a growing emphasis on the relationship between the complexity and diversity of the microor-
ganisms that inhabit our gut (human gastrointestinal microbiota) and health/disease, including brain
health and disorders of the central nervous system. The microbiota-gut-brain axis is a dynamic matrix of
tissues and organs including the brain, glands, gut, immune cells and gastrointestinal microbiota that
communicate in a complex multidirectional manner to maintain homeostasis. Changes in this envi-
ronment can lead to a broad spectrum of physiological and behavioural effects including hypothalamic-
pituitary-adrenal (HPA) axis activation, and altered activity of neurotransmitter systems and immune
function. While an appropriate, co-ordinated physiological response, such as an immune or stress
response are necessary for survival, a dysfunctional response can be detrimental to the host contributing
to the development of a number of CNS disorders.
In this review, the involvement of the gastrointestinal microbiota in stress-mediated and immune-
mediated modulation of neuroendocrine, immune and neurotransmitter systems and the consequen-
tial behaviour is considered. We also focus on the mechanisms by which commensal gut microbiota can
regulate neuroinﬂammation and further aim to exploit our understanding of their role in stress-related
disorders as a consequence of neuroinﬂammatory processes.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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1.1. The microbiome
The human gut plays host to a multitude of microorganisms
(bacteria, archaea, yeasts, single-celled eukaryotes, as well as hel-
minth parasites and viruses, including bacteriophage) collectively
referred to as the microbiota (Eckburg et al., 2005; Gaci et al., 2014;
Scarpellini et al., 2015; Williamson et al., 2015). The gut microbiota
forms part of a complex network termed the microbiota-gut-brain
axis along with the enteric nervous system, sympathetic and
parasympathetic divisions of the autonomic nervous system, and
neuroendocrine and neuroimmune components of the central
nervous system (Cryan and Dinan, 2015b; Mayer et al., 2014; Rhee
et al., 2009). The composition of the core bacteria that we harbour
throughout our adult life is established early in our ﬁrst few years of
life and are shaped by a number of factors including mode of de-
livery (vaginal or C-section), whether we are breastfed or bottlefed,
diet, medication (in particular antibiotic medication), and exposure
to viral or bacterial infections and stress (Borre et al., 2014b). It is
worth noting that the critical development period in which the
seeding of our core microbiota and the development of the bacte-
rial community in our gut, occurs in parallel with the growth,
maturation and sprouting of neurons in the young brain (Borre
et al., 2014a, 2014b), and a similar proﬁle is evident in old age
where a decline in microbiota complexity and diversity occurs in
parallel with a decrease in neuronal complexity (Biagi et al., 2012).
With an estimated mass of 1e2 kg, numbering in their trillions
(Frank and Pace, 2008) and together possessing 100 times the
number of genes in the human genome (Kurokawa et al., 2007),
these microbes can inﬂuence virtually all aspects of human physi-
ology and biology, through interactions with their host (Allez et al.,
2007; Burokas et al., 2015b; Cryan and Dinan, 2012; 2015b; Dinan
et al., 2015; Mayer et al., 2014, Mayer et al., 2015; Moloney et al.,
2014; Sampson and Mazmanian, 2015; Williamson et al., 2015).
This interaction between the bacteria and host is mutually bene-
ﬁcial with the bacteria involved in energy regulation, gut barrier
function, protection from pathogens, and immune system function
amongst others (Bengmark, 2013; Borre et al., 2014a; Burokas et al.,
2015b; Collins et al., 2012; Cryan and Dinan, 2015a), while the host
provides the nutrients and environment in which the bacteria can
thrive. Recently, the gastrointestinal microbiota has also emerged
as a key regulator of centrally mediated events including stress and
neuroinﬂammation (Cryan and Dinan, 2015a; Dinan and Cryan,
2012; El Aidy et al., 2015; El Aidy et al., 2014; Moloney et al.,
2014; Sampson and Mazmanian, 2015). A recent hypothesis is
that this neuronal development is mediated by microbiota-
governed maturation and activation of central microglia. The
concept of the intestinal microbiota as a key regulator of the stress
and/or immune response, facilitating adaption or habituation to
these conditions, and protecting against the development of stress-
related and/or neuroinﬂammation-related disease and dysfunction
will be discussed. Wewill ﬁrst focus on the interaction of stress and
neuroinﬂammation, and then outline the role of gastrointestinal
microbiota in the stress/immune response.1.2. The stress response
Stress may be deﬁned as a complex dynamic condition in which
the homeostasis, or the steady state internal milieu of an organism
is disturbed or threatened (De Kloet et al., 1994; McEwen et al.,
2015; Wilder, 1995). At some stage in their lifespan, all organisms
are exposed to factors that surpass a homeostatic threshold,
resulting in a stress response, be they physical, psychological or
immunological in nature. Evolution has equipped most organisms
with the biological machinery necessary to mount a defensive
response to acute stressful stimulus, and to restore homeostatic
balance once the stress or perceived threat has subsided. The co-
ordination of this defensive response is governed by a pathway
linking the hypothalamus, the pituitary gland and the adrenal
glands, (the hypothalamic-pituitary-adrenal (HPA) axis), ultimately
resulting in the release of behaviour-altering chemicals including
glucocorticoids, mineralocorticoids and catecholamines. The ac-
tivity of the HPA axis is regulated by multiple afferent sympathetic,
parasympathetic, and limbic circuits (e.g., amygdala, hippocampus,
and medial prefrontal cortex) innervating either directly or indi-
rectly the paraventricular nucleus (PVN) of the hypothalamus
(Smith and Vale, 2006). Under normal conditions, HPA axis activity
exhibits a continuous oscillatory activity synchronised with circa-
dian and ultradian rhythms (Dallman et al., 1994; Dickmeis et al.,
2013; Lightman, 2008; Tsigos and Chrousos, 2002). The sympa-
thetic nervous system (SNS) and HPA axis activation are the prin-
cipal neurotransmitter and neuroendocrine components of the
response to stress, respectively (Mayer, 2000). In response to stress,
the SNS is responsible for recruiting increased catecholamine levels
in systemic circulation and tissues, while concomitantly, cortico-
sterone releasing factor (CRF) is released from paraventricular
neurons of the hypothalamus, which then stimulate the release of
adrenocorticotrophic hormone (ACTH) from the anterior pituitary,
which travels in the systemic circulation to induce the synthesis
and release of glucocorticoids from the adrenal cortex: cortisol in
humans and corticosterone in animals. The primary function of SNS
and HPA axis activation is to prime the body for ‘ﬁght or ﬂight’
response by increasing blood sugar through gluconeogenesis,
suppression of the immune system (cytokine suppression) and
enhanced fat and protein metabolism (Mayer, 2000). In response to
a stressful stimulus, glucocorticoids pass into the brain more
readily and mediate their effects through high afﬁnity mineralo-
corticoid receptors and lower afﬁnity glucocorticoid receptors: the
latter being activated at higher stress intensity. Receptors sensitive
to glucocorticoids are expressed throughout the CNS including in
the very same brain regions, and neuronal circuits, involved in the
mounting of a stress-mediated neuroendocrine response, and thus
an autoregulatory feedback loop is in place to prevent over-
activation of this response once the stressor is removed. Chronic
exposure to stress and subsequent glucocorticoid production re-
sults in various adverse side effects such as osteoporosis, diabetes,
hypertension, dyslipidemia, and even neurodegeneration (Howell
and Muglia, 2006; Kleiman and Tuckermann, 2007). Stress is also
one of the most signiﬁcant risk factors for irritable bowel syndrome
(Dinan et al., 2010; Elsenbruch, 2011; Mayer, 2000). On the other
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clinic in a wide range of autoimmune and inﬂammatory diseases.
Glucocorticoids also strongly inﬂuence the phenotype, survival and
functions of monocytes, macrophages and glial cells and their re-
ceptors are ubiquitously expressed on practically every type of
immune cell (Bellavance and Rivest, 2014; Sierra et al., 2008).
2. Stress & neuroimmune function
2.1. Microglia ekey regulators of stress & neuroinﬂammation
In the CNS, the microglia are the innate sentinel immune cells
that can detect subtle changes in molecules in their locality (Kim
and de Vellis, 2005; Tremblay et al., 2011), and ultimately are
responsible for neuroinﬂammatory processes (Kettenmann et al.,
2011; Ransohoff et al., 2015; Yamasaki et al., 2014). These resident
cells compromising 5e12% of total brain cells, are highly ramiﬁed
and extremely plastic, and once activated can release a number of
cytokines and chemokines, express numerous antigenic markers,
regulate neurotransmitters and undergo extreme morphological
changes (Pocock and Kettenmann, 2007). Cytokines, together with
neurotransmitters and hormones, play a key role in the mainte-
nance of neuro-immune-endocrine system homeostasis (Alboni
and Maggi, 2015; Schafer and Stevens, 2015). The cytokine system
(constituted by cytokines, their receptors and regulators of their
activity) are expressed throughout the brain and their expression is
regulated thoughout the lifespan from brain development until
aging. Almost all populations of cells in the brain are susceptible to
modulation by the cytokine system. Under normal physiological
conditions, cytokines typically participate in brain development
and plasticity by translating environmental cues into molecular
signals, and are criticial in the maintenance of healthy brain func-
tion and plasticity (Beattie et al., 2002; Bilbo and Schwarz, 2009,
2012). Cytokines and chemokines also play a key role in the
repair of damaged tissue and the restoration of homeostasis (Charo
and Ransohoff, 2006), and in signalling between immune cells.
Cytokines are generally classed as pro-inﬂammatory or anti-
inﬂammatory which facilitate or inhibit inﬂammatory processes
respectively. Interleukin (IL)-1b, IL-6 and tumour necrosis factor a
(TNFa) are amongst the most widely investigated proinﬂammatory
cytokines, whilst IL-4 and IL-10 are well-known anti-inﬂammatory
cytokines. With the exception of IFN-gamma mRNA, transcripts for
the other cytokines were found to be constitutively present in the
brain (Pitossi et al., 1997). The mobilisation of these anti- and pro-
inﬂammatory cytokines and chemical messengers are beneﬁcial to
the host by allowing the body to defend against infection or tissue
damage. However, a delicate balance between pro-inﬂammatory or
anti-inﬂammatory alterations needs to be tightly regulated, as an
uncontrolled and sustained response can have signiﬁcant inﬂam-
matory collateral damage and detrimental effects on mood and
behaviour.
2.2. Reciprocal involvement of stress and immune systems
Acknowledging the intricate nature of the stress and neuro-
inﬂammatory responses, it is not surprising to note that glucocor-
ticoid receptors are highly expressed on microglia throughout the
brain (Sierra et al., 2008), while integration of stress-induced sig-
nalling is facilitated in the brain by microglia-mediated neuro-
inﬂammatory signalling (Wohleb et al., 2014b). Under stressful
situations, neuroendocrine pathways alter peripheral and central
immune responses, leading to monocyte priming and trafﬁcking,
subsequent alterations in microglia phenotype and, ultimately
resulting in neuroinﬂammation (Delpech et al., 2015; Frank et al.,
2007, 2012; Johnson et al., 2005; Tynan et al., 2010; Wohleb et al.,2014b), which can subsequently lead to a number of psychiatric
disorders, including stress, anxiety and depression (Hodes et al.,
2015; Miller, 1998). The release of cytokines following microglia
activation have been reported to have a causal role in behavioural
phenotype in stress models (Blandino et al., 2013; Hinwood et al.,
2012, 2013; Kreisel et al., 2014; Wohleb et al., 2013). Intriguingly,
stress-inducedmicroglia activation occurs in discrete brain regions,
and in speciﬁc neuronal circuits, heavily involved in stress-
mediated neuroendocrine activation. Accordingly, strong evidence
exists directly linking cytokines with HPA axis activity (Bellavance
and Rivest, 2012, 2014; Jara et al., 2006; Mastorakos and Ilias,
2000, 2006; Mulla and Buckingham, 1999; Savastano et al., 1994).
An immunogenic insult can also trigger HPA axis activity through
immunomodulators traversing the chorus plexus (Kunis et al.,
2013) and BBB (Capuron and Miller, 2011; Turrin and Rivest,
2004). The choroid plexus, whose activity is governed by resident
CD4þ IFNg-producing helper T-cells, is generally considered as a
gate for leukocyte trafﬁcking to the CNS. An increase in circulating
immunomodulators triggers an opening of this gate, facilitating
neuroinﬂammation, and the mounting of a stress response.
Depending on the intensity and nature of the insult, an increase in
systemic immunomodulators may also cause neuroinﬂammation
indirectly by relaying their information via cytokines from endo-
thelial cells of capillaries at the blood brain barrier (Verma et al.,
2006), or via vagal nerve stimulation by peripheral inﬂammatory
mediators (Eskandari et al., 2003). Nerve endings of the vagus
nerve can detect the release of inﬂammatory mediators from the
gut, and communicate this sensory information to the brainstem,
resulting in efferent cholinergic vagal suppression of peripheral
inﬂammatory cytokines, such as TNF a and IL-1b in the spleen
(Rosas-Ballina and Tracey, 2009; Tracey, 2007). Thus, in addition to
their fundamental physiological signiﬁcance independently, a
greater appreciation of the reciprocal interaction of stress and im-
mune responses may prove useful in understanding the aetiology
of stress- and neuroinﬂammatory-related disorders and in devel-
oping new approaches for their treatment. Aberrant regulation of
neuroendocrine, and immune responses are believed to play a key
role in the precipitation, maintenance, and/or exacerbation of a
number of neuroinﬂammatory- and stress-related disorders
including anxiety, depression, Alzheimer's disease, multiple scle-
rosis, arthritis and autism amongst others.
3. Microbiota-gut-brain axis governing immune and stress
response
3.1. Gastrointestinal microbiota-mediated modulation of
behavioural response to stress
Preclinical studies have illuminated our understanding of the
role of the microbiota in behavioural responses, however for the
purpose of this review we will focus on behavioural responses to
stress and neuroinﬂammation. It has been shown that different
types of psychological stress includingmaternal separation, chronic
social defeat, restraint conditions, crowding, heat stress, and
acoustic stress can alter the composition of gastrointestinal
microbiota (Bailey, 2014; Bailey et al., 2011; Bharwani et al., 2015;
De Palma et al., 2015; De Palma et al., 2014; Hsiao et al., 2013;
Moloney et al., 2014), as can stress-related disorders such as irri-
table bowel syndrome (IBS) (Jeffery et al., 2012; Shankar et al.,
2015). As such, a number of experimental models and conditions
have been employed to interrogate the role of the microbiota in
stress behaviour including prebiotic and probiotic intervention,
antibiotic administration, faecal transplantation and the use of
germ-free and speciﬁc pathogen free animals.
Studies have shown that animals raised in a sterile environment
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free), exhibit an exaggerated hypothalamic-pituitary-adrenal axis
activity with elevated ACTH and corticosterone levels in response
to a mild novel arena stressor (Clarke et al., 2013) and in the more
stressful restraint test (Sudo, 2012; Sudo et al., 2004), which nor-
malised after colonisation with commensal bacteria from control
mice. Furthermore, germ-free animals display an anxiolytic
phenotype in mildly stressful novel and aversive environments
including elevated plus maze, light/dark box and open ﬁeld test
(Clarke et al., 2013; De Palma et al., 2015; Neufeld et al., 2011a,
2011b). Recolonisation of germ-free mice with commensal bacte-
ria in early life was sufﬁcient to reverse some of the observed
behavioural and neurochemical effects although only in males
(Clarke et al., 2013). In contrast, a recent study using a different
strain of mice demonstrated that short-term colonisation with
intragastic inoculation of commensal bacteria (Biﬁdobacterium
infantis and Blautia coccoides) reduced anxiety-like behaviour as
compared with the germ-free controls (Nishino et al., 2013). In a
separate study using stress-sensitive germ-free rats, an increased
corticosterone response was reported in germ-free animals
following open ﬁeld test exposure (Crumeyrolle-Arias et al., 2014).
Taken together, these data suggest that the relationship between
gut microbiota and stress- and/or anxiety-related phenotype may
be subject to temporal, sex, strain and species dependent factors.
An alternate approach to investigating the role of the gastroin-
testinal microbiota on stress biochemistry and behaviour is to
diminish stable core bacteria using antibiotic interventions. How-
ever, preclinical and clinical studies investigating the effects of
antibiotic administration on changes in neuroendocrine levels in
response to stress are surprisingly lacking (Ait-Belgnaoui et al.,
2012; Beijers et al., 2010; Desbonnet et al., 2015b; Matsuo et al.,
2009; O'Mahony et al., 2014; Reber et al., 2011), yet they support
the ﬁnding that antibiotic administration was able to prevent
stress-mediated changes in behaviour and immunosuppression
(Ait-Belgnaoui et al., 2012; Reber et al., 2011). A separate study
where disruption of bacterial colonisation was mitigated by van-
comycin reported decreased microbiota diversity and an increased
sensitivity to visceral pain (O'Mahony et al., 2014). Whilst antibiotic
use in healthy infants disrupts the diversity and complexity of
commensal bacteria, it has also been postulated to exacerbate in-
ﬂammatory responses in subjects with a pre-existing susceptibility
to inﬂammatory disorders such as Crohn's disease (Gevers et al.,
2014). However, as a general concept, the use of antibiotics alone
to treat stress-mediated disorders in clinical trials has not been
evaluated.
Allying with the premise that gastrointestinal bacteria can
impact on emotional behaviour and stress response, a number of
studies have investigated the effect of prebiotic and probiotic
intervention in preclinical stress models. Maternal separation is a
useful translational animal model to represent early life stress in
humans, with long term changes in behaviour and gastrointestinal
microbiota complexity/diversity in adulthood in rats (Golubeva
et al., 2015). In this model, Biﬁdobacterium infantis intervention
attenuated immune changes, and normalised the behavioural
phenotype without restoring HPA axis activity in one study
(Desbonnet et al., 2010), while in a similar model, probiotics
reduced the stress-induced increase in corticosterone (Gareau
et al., 2007). In a separate study, maternal probiotic intervention
(Biﬁdobacterium animalis subspecies lactis BB-12 and Propioni-
bacterium jensenii 702) induced activation of neonatal stress
pathways and improved the immune environment of stressed an-
imals and protected, in part, against stress-induced disturbances in
adult gut microﬂora (Barouei et al., 2012). Furthermore, maternal
separation was shown to exacerbate visceral hypersensitivity in
mice (Moloney et al., 2012; Tramullas et al., 2014) and ratsgenetically predisposed to display an anxious phenotype (Hyland
et al., 2015), an effect that was reversible with probiotic adminis-
tration of Biﬁdobacterium infantis 35624 (McKernan et al., 2010).
Probiotic treatments (Biﬁdobacterium longum 1714, and Biﬁdo-
bacterium breve 1205; lactobacillus strain) were also successful in
reversing behavioural alterations without altering neuroendocrine
output in restraint and food deprivation tests (Palomar et al., 2014;
Savignac et al., 2014). In the forced swim test, 28 day Lactobacillus
rhamnosus (JB-1) administration reduced stress-induced cortico-
sterone levels, an effect that was abolished with vagotomy, sug-
gesting that a functional neural relay from gut to brain is necessary
for governing stress response (Bravo et al., 2011). Another study
demonstrated that the HPA axis response to acute stress was
attenuated by lactobacillus farciminis (Ait-Belgnaoui et al., 2012).
Recently, we have demonstrated that a combination of the pre-
biotics fructooligosaccharide (FOS) and galactooligosaccharide
(GOS) attenuated the corticosterone response to acute swim stress
and attenuated anxiety related behaviour in naïvemice, and further
demonstrated a protective effect of this cocktail on stress and
anxiety parameters in chronic social defeat (Burokas et al., 2015a).
Similarly, a prebiotic cocktail of non-digestible oligosaccharides
demonstrated anxiolytic activity as well as an immunosuppressive
effect in response to LPS (Savignac et al., 2015).
In a clinical setting, the number of studies investigating the ef-
fects of prebiotic or probiotic supplements on stress behaviour and
output are limited. Using cortisol as an index of stress response, the
probiotics Lactobacillus helveticus R0052 and Biﬁdobacterium lon-
gum R0175 (Messaoudi et al., 2011a, 2011b) and gal-
actooligosaccharide prebiotic (Schmidt et al., 2015) were effective
in boosting the subjects resilience to stress and improved
emotional responses in healthy subjects. Lactic acid-producing
bacteria have been shown to alleviate abdominal discomfort and
IBS symptoms in clinical settings (Clarke et al., 2012). Furthermore,
ingestion of a probiotic cocktail was shown to alter brain activity
and informational processing of emotional material in a functional
magnetic resonance imaging brain scan study (Tillisch et al., 2013),
as well as reducing negative thoughts associated with sad mood
(Steenbergen et al., 2015) reinforcing the role for gastrointestinal
microbiota in stress and emotional responses. However, the precise
mechanisms that orchestrate a functionally relevant communica-
tion between the microbiota and the stress response are yet to be
elucidated.
3.2. Regulation of the neuroinﬂammatory response by
gastrointestinal microbiota
The gut microbiota inﬂuences the relative populations, migra-
tion and function of various subsets of immune cells (Dorrestein
et al., 2014), and a spate of recent publications have demon-
strated how the microbial population of the gut can modulate
innate and adaptive immune responses at mucosal surfaces during
infection, inﬂammation and autoimmunity (Cassel et al., 2008; El
Aidy et al., 2014; Kamada et al., 2013; Mazmanian et al., 2005;
Round and Mazmanian, 2009). More recently, changes in cross-
talk between the intestinal epithelium, the intestinal immune
system and gut microbes has been recognised for its ability to
modulate systemic immunity (Belkaid and Naik, 2013). However,
until very recently, the interaction between gastrointestinal
microbiota and CNS-restricted immune cells had not been
investigated.
Along with their established role in host defence, the constitu-
tively active microglia are critically involved in neuronal events at
various stages in development and adulthood, including synaptic
remodelling to improve neuronal network signalling (Schafer et al.,
2012; Schafer and Stevens, 2015). Despite the seclusion of the
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hensive study (Erny et al., 2015) has highlighted a critical role for
gastrointestinal microbiota in microglia maturation, morphology
and immunological function. Under normal homeostatic condi-
tions, a diverse gastrointestinal microbiota is necessary for the
maintenance of microglia in a healthy functional state. In contrast,
the absence of a complex host microbiota (as evidenced by germ
free models, antibiotic suppression of microbiota or use of speciﬁc
pathogen free (SPF) mice) led to increased microglial populations;
defects in microglia maturation, activation state and differentia-
tion; alterations to microglia morphology (with longer processes
and increased branching, terminal points and clubbing at synaptic
boutons); and a compromised immune response to bacterial or
viral infection (Erny et al., 2015). The observed alterations in
microglial phenotype were reversed with recolonisation of gut
microbiota, following 6 weeks co-habitation of germ-free mice
with control mice. The ﬁndings from this study have redeﬁned the
ideology that the relationship between our microbiota, immune
system and neurodevelopment is moot in adulthood; as a healthy,
and diverse gastrointestinal microbiota is essential for the contin-
uous preservation of healthy microglia and proper brain function
throughout our lifespans (Cryan and Dinan, 2015a). It should also
be noted that minocycline, a semi-synthetic, second-generation
tetracycline analogue can effectively cross the bloodebrain barrier
and has been reported to exert neuroprotective effects in cerebral
ischaemia, traumatic brain injury, amyotrophic lateral sclerosis,
Parkinson's disease, kainic acid treatment, Huntington’ disease,
multiple sclerosis and Alzheimers in various preclinical animal
models (Kim and Suh, 2009); reportedly through suppression of
microglia activation (Tikka and Koistinaho, 2001). However, min-
ocycline has a dual action as an antibiotic and thus may be inﬂu-
encing centrally-mediated events indirectly through microbiota
depletion, where it acts on both gram positive and negative
bacteria.
4. Potential mechanisms of action of gastrointestinal
microbiota on stress and immune systems
Gastrointestinal microorganisms are by their very deﬁnition
constrained to the gut, and interact with the host tissue along the
alimentary canal as well as with their cohabitating microbial con-
sortia. The epithelial layer of the gut has many functions including
regulating the absorption of nutrients and ﬂuid from the lumen of
the intestines and to serve as a physical barrier to invading path-
ogens or harmful substances (Farhadi et al., 2003). This monolayer
is interspersed with complex protein structures known as tight
junction proteins (Madara, 1998), establishing a barrier to prevent
diffusion of ﬂuids and solvents between adjacent epithelial cells
(Ivanov and Naydenov, 2013). Another important function of the
intestines is to limit the contact of intestinal microbiota with the
visceral tissue, which it does by secreting a protective viscous
mucous layer from goblet cells of the epithelium. The exchange of
molecules through the mucous layer and epithelium serve to
facilitate communication between the gut and the immune system
through the recognition of self and non-self antigens (Fasano and
Shea-Donohue, 2005), and thus to prime the immune system to
identify potentially harmful pathogens.
It is evident that the gastrointestinal microbiota plays a key role
in HPA axis activity and immune response, but the question re-
mains; how are the microbiota of the gut modulating physiological
response at a central level? A number of mechanisms have been
suggested, however the precise mechanism or mechanisms of ac-
tion are, as yet, unresolved. Crosstalk in the bi-directional micro-
biome-gut-brain axis, in homeostatic conditions, and in response to
changes in environment, likely involve dynamic molecules withmultiple effector mechanisms that can traverse different anatom-
ical environments and communicate within their local environ-
ment to mediate a complex co-ordinated response on multiple
physiological systems. Numerous molecular candidates have been
proposed including neurotransmitters, neuropeptides, endocrine
hormones and immunomodulators.
This ﬁnal section will consider the likely involvement of the
microbiota in mediating or modulating stress and neuro-
inﬂammation, and their associated behavioural responses. This
section is necessarily speculative as there is a paucity of studies
conclusively linkingmicrobiota-mediated changes locally in the gut
and periphery with central effects. A schematic for the mechanisms
bywhich microbiota can inﬂuence stress and neuroinﬂammation is
provided in Fig. 1.
4.1. The environmental niche of the gastrointestinal microbiota
To better understand the mechanisms by which these
commensal microbes inﬂuence our daily lives, one must ﬁrst un-
derstand their environment. The gastrointestinal tract can govern
microbial density by neurally controlling gut motility, gut perme-
ability, release of gut hormones and immune function via vagal and
pelvic connections between the central nervous system (CNS), and
enteric nervous system (ENS) and sympathetic prevertebral
ganglia. The luminal-mucosal interface of the intestinal tract is the
ﬁrst relevant location where host-microorganism interactions
occur and is highly dependent on immune response. The mucosal
surface layers the epithelial lining of the gut, which contains pre-
dominantly enterocytes, secretory cells and gut associated
lymphoid tissue (GALT) (Pott and Hornef, 2012). The enterocytes
express innate immune receptors and can release cytokines and
chemokines, while the GALT utilise lymphocytes to mount a more
speciﬁc immune response if the case is warranted. The secretory
cells are involved in mucus release from goblet cells, the control of
bacterial diversity by antimicrobial secretion from Paneth cells and
in neuroendocrine control via the release of substances from
enteroendocrine cells such as ghrelin, somatostatin, cholecysto-
kinin, peptide YY and serotonin amongst others (Cani et al., 2013).
Thus the gastrointestinal microbiota have had to adapt to survival
in a somewhat hostile environment where the host intestinal bar-
rier is on constant immunological surveillance.
4.2. Physical communication between the microbiota and the
epithelium
The polysaccharide coating of gastrointestinal bacteria protects
them from degradation but also serves to identify the numerous
and diverse bacteria to the host. This allows the host protective
immune surveillance system to monitor and regulate commensal
bacteria, and to identify invading pathogens. Evidence suggests
that a disruption to homeostatic bacterial diversity could trigger an
increase in immune mediators in the gut, as a consequence of
surplus numbers of certain cell wall components, such as pepti-
doglycans (Royet et al., 2011). Epithelial pattern recognition re-
ceptors (PRRs) recognise molecular patterns unique to bacteria and
other microorganisms (pathogen associated molecular patterns, or
PAMPs) (Duerkop et al., 2009; Vaishnava et al., 2008a) of which the
Toll-like receptor family are the most studied, and once activated
can recruit inﬂammatory mediators, cytokine production and
chemokine-mediated recruitment of acute inﬂammatory cells
(Takeda and Akira, 2004; Vaishnava et al., 2008b). This in turn helps
regulate the number and diversity of bacteria in the gut. However,
in response to invading pathogens or as a consequence of chroni-
cally high inﬂammatory tone, prolonged cytokine production can
weaken the integrity of the intestinal barrier and mucosal layer,
Fig. 1. Schematic for microbiota regulation of neuroinﬂammation and HPA axis activity. Communication within the microbiota-gut-brain axis involves the complex co-ordination of
a number of factors and systems. The microbiota can govern events in the periphery and CNS by various means of communication including vagal nerve activation, cytokine
production, neuropeptide and neurotransmitter release, SCFA release and microbial by-products, and by utilising the lymphatic and systemic circulation. Once these signals
penetrate the blood brain barrier and reach the brain, they can inﬂuence the maturation and activation state of the microglia. Once activated, microglia play a key role in immune
surveillance, synaptic pruning and clearance of debris. They also facilitate a number of everyday functions in the brain, including the regulation of HPA axis activation state. The
release of glucocorticoids (cortisol) as a consequence of HPA axis activation can in turn regulate the activation state of brain microglia, as well as inﬂuence cytokine release and
trafﬁcking of monocytes from the periphery to the brain. HPA Hypothalamic-Pituitary-Adrenal; BDNF Brain derived neurotrophic factor; LTP Long term potentiation; BBB Blood-
brain barrier; GC Glucocorticoids; GR Glucocorticoid receptor; FFAR Free fatty acid receptor; SCFA Short chain fatty acid; NP Neuropeptide; NT Neurotransmitter; DC Dendritic cell;
EEC Enteroendocrine cell.
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a consequence of increased bacteria inﬁltration across the gut
(Souza et al., 2004). This concept that the “leaky gut” may facilitate
communication between the microbiota and inﬂammatory tone
has gained traction, and may be causal in the chronic low-grade
inﬂammation often observed in mood disorders, such as depres-
sion (Kelly et al., 2015).
4.3. Biochemical communication between the microbiota and the
epithelium
It has been estimated that there are greater than 100 species
(Qin et al., 2010) and more than 7000 (Ley et al., 2008) strains of
bacteria in the average human gut, largely dominated by Bacter-
iodetes and Firmicute phylotypes with less prevalence of Proteo-
bacteria, Actinobacteria, Fusobacteria and Verrucomicrobia (Eckburg
et al., 2005). Indeed, the different regions of the gut vary in terms of
the indigenous microbiota diversity (Human Microbiome Project,
2012; Lozupone et al., 2012). These commensal bacteria are
capable of synthesising and releasing many neurotransmitters and
neuromodulators themselves, or evoke enteroendocrine cells into
the synthesis and release of neuropeptides. For example,Lactobacillus and Biﬁdobacterium species can produce gamma-
aminobutyric acid (GABA): Escheridia, Bacillus and Saccharomyces
spp. can produce norepinephrine: Candida, Streptococcus, Escheridia
and Enterococcus spp. can produce 5-HT: Bacillus can produce
dopamine: and Lactobacillus can produce acetylcholine (Lyte, 2013,
2014). These microbially synthesised neurotransmitters can cross
the mucosal layer of the intestines, and possibly mediate effects
locally in the gut, or enter the bloodstream and impact on physi-
ological events in the brain.
Approximately 95% of serotonin in the body is compartmen-
talised in the gut, predominantly in enterochromafﬁn cells of the
mucosa and in nerve terminals of the enteric nervous system.
Studies using germ-free mice have implicated the gastrointestinal
microbiota in impacting on tryptophan metabolism, the precursor
to serotonin (Clarke et al., 2013). It seems likely that the secretion of
these neurotransmitter molecules in the intestinal lumen may
induce epithelial cells to release molecules that can in turn
modulate enteric neural communication, or perhaps these neuro-
transmitters can pass through the intestinal barrier and mediate
effects locally in the gut. Evidence to support a role for gastroin-
testinal microbiota in neural communication between the brain
and gut is provided by studies whereby probiotic-mediated
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2011).
Gastrointestinal bacteria can also secrete bioactive chemicals
such as bacteriocins, bile acids, choline and short chain fatty acids
(SCFAs) that are integral to host health and disease. Bacteriocins are
antibiotic proteins that inhibit the growth of other bacteria in the
vicinity, while SCFAs including butyric acid, acetic acid, proprionic
acid and lactic acid are bacterial metabolites derived from the
fermentation of polysaccharides (Cummings andMacfarlane,1997).
These fatty acids can enter the blood and activate free fatty acid
receptors (FFARs), or mediate epigenetic events (Kasubuchi et al.,
2015) and have been reported to have neuroactive properties
(Russell et al., 2013). Indeed, deﬁcits in BBB permeability of germ-
free animals was partly reversible with colonisation of SCFA-
producing commensal bacteria (Braniste et al., 2014). Similarly,
deﬁcits in germ-free animals in microglia density, morphology and
maturity were reversible with administration of a SCFA mix (so-
dium proprionate, sodium butyrate, and sodium acetate) in the
drinking water (Erny et al., 2015).
4.4. Consequences of microbial interaction
Under homeostatic conditions there exists a healthy, resting
inﬂammatory tone where the microbiota stimulate cytokines and
chemokines release, which in turn regulates local levels of bacteria
in the gut. As well as inﬂuencing local immune responses at the
epithelium, microbiota can synthesise and release neurotransmit-
ters and SCFAs, as well as inﬂuence the release of neuropeptides
and hormones from enteroendocrine cells of the intestines. Gut
peptides such as ghrelin, gastrin, orexin, galanin, cholecystokinin,
leptin and neuropeptide Y are thought to inﬂuence peripheral
neural communication and can also act centrally to inﬂuence
behaviour. Current hypotheses suggest that these circulating cy-
tokines, chemokines, endocrine messengers and microbial by-
products can inﬁltrate the blood and lymphatic systems, or inﬂu-
ence neural messages carried by the vagal and spinal afferent
neurons to impact on centrally-mediated events, including regu-
lation of HPA axis activity and neuroinﬂammation.
4.5. Penetrating the blood brain barrier
Until recently, the central nervous system was considered an
immune privileged entity lacking a lymphatic drainage system
(Aspelund et al., 2015; Louveau et al., 2015). Despite the observa-
tion of this lymphatic drainage system in the brain, themigration of
immune cells, cytokines, chemokines, endocrine messengers and
microbial by-products is still tightly regulated by the blood brain
barrier (BBB), a highly capillarised structure composed of astrocytes
and endothelial cells, amongst others. The permeability of this
barrier can be compromised in certain physiological conditions,
including in response to stress, infection or injury, allowing the
inﬂux and egress of messenger molecules to inﬂuence the ho-
meostatic environment in the brain. Anatomical loci where these
compounds can enter the CNS include the choroid plexus,
meninges, perivascular space and parenchymal tissue (Ransohoff
and Engelhardt, 2012), and each of these stations is under vigi-
lant surveillance by resident macrophage and microglia (Nayak
et al., 2012). These cells are the ﬁrst cells to detect changes in
their environment, and once activated recruit help locally within
the brain but also by recruiting monocyte trafﬁcking to the brain to
aid in defence and cell debris clearing. As with the epithelium of the
gut, pattern recognition receptors (PRRs) on these immune cells
recognisemicrobial by-products, while changes in the environment
as a consequence of cytokines, chemokines and endocrine mes-
sengers ultimately result in neuroinﬂammation, and trafﬁcking ofmonocytes to the brain. Whilst the multimodal inﬂuence of
microbiota on physiological events at the level of the CNS has
gained credence, more recently there has been a shift to a stronger
role for microbiota in regulating neuroinﬂammation via interven-
tion in the recruitment of local immune regulators from the pe-
riphery to the brain.
4.6. Peripheral inﬂuence of microbiota regulating
neuroinﬂammation and HPA axis
Emerging evidence implicates a novel neuroimmune circuit
involving microglia activation and altered sympathetic neural tone
to the peripheral immune system to recruit inﬂammatory mono-
cytes to the brain (Wohleb et al., 2014b), and further reinforce
stress-related behaviours. The trafﬁcking of these monocytes to the
brain appeared to be governed by TNF a-mediated microglia acti-
vation (D'Mello et al., 2009) and was reversible by probiotic inter-
vention with VSL#3 (D'Mello et al., 2015). Indeed, the mediation of
certain behavioural phenotypes as a consequence of prolonged HPA
activation, involves the trafﬁcking of monocyte from the spleen
(Wohleb et al., 2014a, 2014b), a tissue with high density of FFAR2
receptors (Erny et al., 2015). These FFAR2 receptors are Gi/Go G-
protein coupled receptors and have been localised to lymphocytes
(Nilsson et al., 2003). SCFAs, the natural ligands for FFARs, were
shown to reverse the detrimental effects on microglia density,
morphology and maturity in the absence of a complex microbiota
(Erny et al., 2015). Taken together these ﬁndings suggest that
gastrointestinal microbiota may govern centrally mediated events
indirectly through regulation of monocyte trafﬁcking to the brain
and subsequent microglia activation and HPA axis activity, possibly
via SCFA-mediated mechanisms.
5. Neuroinﬂammation, stress and microbiota at critical time
windows
5.1. Early life
Childhood and adolescence represent the most dynamic periods
of change in our gastrointestinal microbiome, as well as our
neuronal development. The formation of our central nervous sys-
tem require a complex and well-orchestrated series of events
including neurogenesis, axonal and dendritic growth, synapto-
genesis, and reﬁnement of these connections. The ﬁrst two weeks
of postnatal development are a period of remarkable plasticity with
new synapses being actively formed and remodelled (Tremblay
et al., 2011). Initially, far more synaptic connections than neces-
sary are created, and by a microglia-governed process termed
‘pruning’ (Hong et al., 2016; Paolicelli et al., 2011; Bilimoria and
Stevens, 2015; Schafer and Stevens, 2015), a large number of
these immature synapses are permanently eliminated while a
subset of synapses are maintained and strengthened (Schafer et al.,
2012, 2013). During and shortly after birth, infants are expose to
microbes originating predominantly from the mother. Initially, the
mode of delivery (C-section versus vaginally born) will inﬂuence
the very ﬁrst seeding of the gastrointestinal microbiota, followed
thereafter bywhether the infant is breast- or bottle-fed (Borre et al.,
2014a, 2014b; O'Mahony et al., 2015). Given the evidence presented
herein, it is tempting to speculate that the microbes that populate
our gut in early life inﬂuence our neural development via microglia
activation. As such, disruptions (such as stress or antibiotic medi-
cation) to our microbiota at these critical periods of dynamic
microbiota-host interactions have the potential to profoundly alter
gut-brain signalling, affect health throughout life and increase the
risk of (or lead to) neurodevelopmental disorders. A recent
comprehensive review (Ganguly and Brenhouse, 2015) has looked
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plicates a differential role for microglia at different stages in life to
subsequent stress exposure, as well as in various
psychopathologies.
5.1.1. Adolescence
Subsequent to the initial colonisation at birth and through in-
fancy, the microbiota continues to develop throughout childhood
and adolescence. Currently, there is a lack of studies investigating
the effects of hormonal changes at puberty on the diversity and
complexity of commensal gut bacteria, or whether any such
changes are sexually dimorphic. At this developmental stage,
distinct changes in neuronal architecture and function occur in
adolescence that facilitate the maturation of behavioural, social and
cognitive skills (Burnett et al., 2011). It is also a period of increased
behavioural and susceptibility to various psychiatric vulnerabilities,
including schizophrenia, substance abuse, irritable bowel and
mood disorders (O'Connor and Cryan, 2014). Adolescence is
generally considered to beginwith the onset of puberty and ends as
one takes on adult social roles (Dahl, 2004; Spear, 2004). Human
structural imaging studies have demonstrated a loss of gray matter
during adolescence (Sowell et al., 1999, 2001), with gray-matter
reductions in portions of the temporal lobe and cortical regions
(dorsal PFC) occurring in late adolescence (Raznahan et al., 2011;
Sowell et al., 1999, 2004). Preclinical studies suggest that these
changes are related to pruning of synapses during this develop-
mental period (Rakic et al., 1986, 1994; Rakic, 1999), most likely via
microglial interaction (Hong et al., 2016; Paolicelli et al., 2011;
Bilimoria and Stevens, 2015; Schafer and Stevens, 2015). This pro-
cess of remodelling continues beyond adolescence into the third
decade of life before stabilising at adult levels (Petanjek et al., 2011).
Further preclinical evidence using antibiotic depletion of the
microbiota during adolescence has also demonstrated a role for the
microbiota in anxiety and cognitive behaviours at this develop-
mental time window, as well as regulating neuromodulators of the
microbiota-gut-brain axis (Desbonnet et al., 2015a).
5.2. Adulthood and aging
As adulthood approaches, the gut microbiota stabilises and be-
comesmore diverse (Palmer et al., 2007), and can resist detrimental
environmental elements such as antibiotics and stress by restoring
its diverse and stable ‘normal’ core microbiota (Rajilic-Stojanovic
et al., 2012). However, as we age, our microbiota diversity and
stability decline (Biagi et al., 2010), and there is a concomitant in-
crease in number, size and activation of microglia (von Bernhardi
et al., 2015) that can lead to an increased inﬂammatory tone
termed ‘inﬂammaging’ (Franceschi et al., 2007). There is high het-
erogeneity of microglia in various neurodegenerative diseases,
including Alzheimers disease and those phenotypes share common
characteristics with aging (Bachstetter et al., 2015). In normal aging,
close crosstalk with astrocytes, neurons and other brain cells, serve
crucial functions as the scavenger system of the CNS, providing
beneﬁcial functions as tissue repair in the CNS. However, chronic,
dysregulated activation of microglia can lead to increased inﬂam-
matory tone ultimately resulting in malfunction and damage of
brain cells. What drives this dysregulation is not fully understood,
and as yet, the role of the microbiota in this has not been fully
investigated.
6. Concluding remarks
The gastrointestinal microbiota has recently emerged as a key
facilitator of stress adaption and immune response in the body. At
the behavioural level, gastrointestinal content and complexity canimpact on anxiety and fear responses, and can reduce behavioural
despair or anhedonia. The evidence presented herein suggests that
resilience to stress- and immune-related disorders and dysfunction
of stress- and immune-systems may be dependent on the diversity
and complexity of gastrointestinal microbiota. The studies inves-
tigating the inﬂuence of gastrointestinal microbiota have been
largely preclinical in nature, with the ﬁndings in clinical cohorts
being diagnostic in nature, and further studies with pre- and pro-
biotic interventions are warranted. The ultimate goal is to exploit
our understanding of the role of gastrointestinal microbiota in
fundamental physiological and pathophysiological processes to
better understand and treat a range of stress- and immune-related
disorders. The studies covered in this review illustrate the
numerous complex relationships between gastrointestinal micro-
biota and the stress and immune responses. However, commensal
microbiota-mediated causality of the physiological and behaviour
responses to stress and neuroinﬂammation is still unconﬁrmed.
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